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Asthma has a more favourable prognosis than chronic obstructive pulmonary disease (COPD), based on studies 
including few asthmatics and few women with COPD. We assessed differences in mortality between people 
attending the emergency room for asthma and for COPD in a population-based cohort. 
We recruited all the men and women, who were residents of Barcelona (Spain) over 14 years of age, who attended 
emergency room services for an obstructive lung disease during the period 1985-1989. Vital status was followed up 
to the end of 1995. A total of 15 517 individuals (including 4555 asthmatics and 2194 females with COPD) were 
studied. Mortality was ascertained using a record linkage with the regional Mortality Registry. 
Overall, 43.6% people died during the follow-up period. Mortality was higher among individuals with COPD 
than with asthma, in males and females, for all causes of death, as well as for cancer, cardiovascular and respiratory 
causes. After adjusting for age, the relative risk (RR) of dying of a male attending for COPD and discharged home 
was 1.50 (1.29-l .74) in comparison with a male attending for asthma, and 3.06 (2.66-3.5 1) for a male attending for 
COPD and admitted into the hospital. Similar figures were found for females. The increased risk for patients with 
COPD was significantly higher than for asthma in all age groups. 
Both males and females with asthma have a more favourable prognosis than patients with COPD, for all age 
groups. 
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Introduction 
It is generally accepted that patients with an obstructive 
lung disease have a poorer survival than expected (1) and 
that degree of bronchial obstruction (indicated by reduced 
forced expiratory volume in the first second) is a risk factor 
of mortality (2). Most studies on the natural history of 
chronic obstructive pulmonary disease (COPD) have 
included a preponderance of men and excluded patients 
with asthma (3-6). Although longitudinal studies in The 
Netherlands (7) and in Tucson (8) did not exclude 
individuals with asthma, these studies included a relatively 
small number of subjects with the disease and, particularly, 
of females with COPD. These studies reported that the 
overall course in patients with an asthmatic type of chronic 
non-specific lung disease was more favourable than in 
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patients with a combination of emphysematous changes 
and permanent bronchial obstruction (7,8). 
We performed an 1 l-year retrospective follow-up of the 
vital status of a large cohort consisting of individuals 
attending emergency room services in Barcelona for asthma 
and COPD during the period 1985-89. We assessed the 
mortality of this cohort both in males and females, 
particularly the relative risk of dying among patients with 
COPD in comparison to patients with asthma. 
Methods 
Daily emergency room visits of Barcelona residents with 
asthma or chronic obstructive pulmonary disease (COPD), 
over 14 years of age, were recorded during the years 1985- 
1989. Data were collected from the clinical records of the 
four largest urban hospitals, which covered around 80% of 
all Barcelona asthma and COPD emergency room visits (9). 
The clinical records of all daily visits were reviewed and 
those in the diagnostics section which matched a list drawn 
up by a panel of chest physicians were selected. Using this 
information, and if necessary other data contained in the 
clinical records, emergency room visits were classified as 
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asthma, COPD or other respiratory causes as explained 
elsewhere (9,lO). Briefly, asthma referred to an attack of 
asthma, shortness of breath, or bronchospasm, whereas 
COPD referred to an exacerbation of chronic bronchitis or 
emphysema. Subjects with bronchospams or an attack of 
shortness of breath and a concomitant diagnosis of COPD 
were classified as COPD. A reliability study of the register 
showed that identification of asthma emergencies was 
highly reliable (Kappa value, IC= 081) as was the agree- 
ment after restriction to only individuals with asthma or 
COPD (K = 0.91) (9). A validity study showed that 92% of 
individuals classified as asthmatics were patients with 
asthma (unpublished data). In order to group together 
episodes referring to the same individual we employed a 
‘flexible deterministic record linkage’, described elsewhere 
(11). Follow-up started at the first visit to emergency room 
services during the period 198589. Mortality was ascer- 
tained using a record linkage of the cohort individuals with 
the Catalonia Mortality Registry for the years 1985595 
(11). Fields used for linkage were full name, sex and year of 
birth. People not detected as dead in the Mortality Registry 
were considered alive at the end of the study period (31 
December 1995). 
All analyses were stratified by sex, due to the marked 
differences in diagnosis and mortality by sex. Mortality rate 
ratios were calculated using the person-year method. 
Specific mortality rates per age group were compared by 
diagnosis using the Poisson regression (12). The assessment 
of relative risks of dying by diagnosis was repeated using 
survival analyses (Cox regression), which allow controlling 
for age in a much finer way. Survival methods employed 
age as the time scale with staggered entry (12), using the 
STATA statistical package. In accordance with the study 
design we carried out two distinct analyses corresponding 
to the periods 1985-89 and 1990-95. During 1985-89, the 
units of analysis were the individual periods corresponding 
to the age spans after an individual had had a visit with a 
given diagnosis and severity (discharge or referral). An 
individual contributed in as many individual periods as 
visits to emergency services. The analysis carried out in the 
second period allowed determination of the effect of the 
individual history experienced during the period 1985589 
on the hazard of death between 1990 and 1995, after 
restriction to individuals alive at 31 December 1989. This 
analysis allowed adjustment within the same subject for 
discordant diagnosis of asthma or COPD (13). 
Results 
Overall, 15 517 individuals were followed up, including 
4555 who were diagnosed with asthma, 9987 of COPD 
(2194) females) and 975 of both diagnoses in repeated 
visits. The proportion of individuals diagnosed with COPD 
in emergency rooms increased significantly with age, 
coinciding with a decrease in asthma, both in males and 
females (Table 1). The proportion of individuals with a 
diagnosis of COPD was larger in males than females. The 
proportion of subjects who had received both diagnoses in 
repeated visits was not related to age, but their average 
number of visits per individual was higher (5.2 per 
individual) than among individuals always diagnosed with 
asthma (1.5) or COPD (1.7). Among men and women, 
51% of patients were discharged home (around 60% of 
asthmatics and 45% of patients with COPD). Only 0.9% 
of males and 0.6% of females were admitted in the 
Intensive Care Unit (ICU). 
Overall, 43.6% (6759 out of 15 517) of the individuals 
died during the follow-up period. Most deaths (90% in 
males and 65% in females) occurred among individuals 
with COPD. Mortality was higher among individuals with 
COPD than among individuals with asthma in both sexes, 
and this occurred at all ages, although the relative risk 
decreased with age in males and females (Table 1). 
TABLE 1. Mortality rate due to all causes by age group, sex and diagnosis in emergency visit (Barcelona 1985-1995) 
Emergency visits 
Percent by diagnosis* Mortality rate x 1000 x year COPD/Asthma ratio 
Sex Age n COPD Asthma COPD Asthma Rate ratio’ Adjusted risk ratio1 
Male 1544 1312 26% 70% 23.64 5.83 4.05 (2.64-6.22) 4.53 (2.47-8.30) 
45-64 3381 78% 14% 60.01 18.28 3.28 (2.56-4.20) 3.62 (2.55-5.13) 
65-74 2527 90% 5% 105.34 44.33 2.38 (1.79-3.16) 2.41 (1.63-3.54) 
>74 2698 94% 3% 174.48 106.77 1.68 (1.30-2.17) 1.60 (1.16-2.21) 
Female 1544 1384 7% 92% 12.60 2.46 5.12 (2.29-l 1.4) 3.20 (0.66-15.4) 
45-64 1538 24% 66% 39.47 10.55 3.74 (2.77-5.05) 4.66 (3.03-7.16) 
65-74 1100 53% 34% 72.32 29.40 2.46 (1.93-3.13) 2.91 (2.04-4.13) 
>74 1577 72% 20% 141.82 87.51 1.62 (1.40-1.88) 1.77 (1.42-2.20) 
*Percentages do not sum to 100% due to the presence of subjects with both diagnoses. 
+Rate ratio and 95% confidence intervals after exclusion of subjects with both diagnoses, using Poisson regression. Period 
1985595. 
fRelative risk adjusted for severity and age, using Cox regression. Period 1985-89. 
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Increased risk of dying among COPD patients was 
observed for cancer, cardiovascular and respiratory causes 
(Table 2). After adjusting for severity of illness at each visit, 
mortality remained higher in COPD patients than in 
asthmatics (Table 3). In addition, for the period 1985-89, 
the relative risk increased consistently with increasing 
severity of COPD. Among asthmatics, being admitted into 
hospital (females) and being admitted into the Intensive 
Care Unit (ICU) (both sexes), was associated with an 
increased risk of dying in comparison to being discharged 
home. Analysis of the period 1990-95 also showed a higher 
relative risk for COPD than asthma and increasing risks by 
severity of the COPD visit. 
Discussion 
Mortality was higher among subjects with COPD than 
with asthma, both in males and in females, and this 
occurred for cancer, cardiovascular and respiratory 
causes. As Burrows (8) has stated, the finding of important 
differences in survival between asthma and COPD 
suggests that one should not group all types of persistent 
airflow obstruction under the same heading. Our study 
included a large population of women, which allows us to 
extend the Burrows view to females, with sufficient 
confidence. In addition, our results coincide with the 
finding in a follow-up study of asthmatics, that a 
concomitant diagnosis of bronchitis increased the risk of 
dying in asthmatics (14). The external validity of these 
findings is limited to severe patients with asthma and 
COPD (i.e. those needing emergency room attendance). 
Misclassification of diagnosis between asthma and COPD 
in emergency rooms may be claimed as a limiting factor in 
the present study. However, our register has been shown 
to be of high reliability and validity in terms of 
distinguishing COPD from asthma (9). In addition, the 
fact that asthma patients had a higher risk of dying due to 
asthma than COPD patients, gave support to the validity 
of the diagnosis in emergency rooms. Moreover, we used 
analytical methods that overcome in part problems of 
misclassification between asthma and COPD, since we 
allowed subjects to contribute to the analysis even with 
discrepant diagnosis at repeated visits. 
We found that an emergency room visit for COPD at 
ages younger than 45 is already an important cause of death 
when comparing with asthmatics. The mortality rate ratios 
between our young males and females with COPD and 
those from the general population were 11.8 and 148, 
respectively (P<O.Ol in both cases). Thus, visiting an 
emergency service for a COPD exacerbation increased the 
risk of dying not only at old ages (where the rate difference 
between COPD and asthma was around 60 deaths per 1000 
individuals per year according to Table l), but also in 
young and middle age groups. At older ages, patients with 
asthma still had a more favourable prognosis than patients 
with COPD, although the relative risk of dying between 
COPD and asthma decreased after the age of 45 years. 
These changes could be due to an increased concomitance 
of the two entities with age, or alternatively because of a 
TABLE 2. Mortality rate by cause of death and diagnosis in emergency visit 
Mortality rate x 1000 x year COPD/Asthma age-adjusted rate ratio 
Causes COPD Asthma 
Male 
All 
Cancer 
Lung cancer 
Cardio-vascular 
Myocardial infarction 
Respiratory 
COPD 
Asthma 
Other 
Female 
All 
Cancer 
Lung cancer 
Cardio-vascular 
Myocardial infarction 
Respiratory 
COPD 
Asthma 
Other 
109.4 17.6 2.89 (2.51-3.24) 
21.1 4.5 2.94 (2.21-3.91) 
8.4 1.8 3.47 (2.22-5.40) 
27.3 3.6 1.82 (1.49-2.23) 
8.4 1.5 2.30 (1.42-3.73) 
43.8 5.0 3.70 (2.85480) 
34.7 2.1 6.95 (4.68-10.3) 
0.9 1.8 0.30 (0.16X.57) 
17.7 4.5 1.84 (1.37-2.48) 
99.0 18.1 1.93 (1.70-2.18) 
8.3 2.6 1.52 (1.05-2.21) 
0.9 0.1 6.17 (1.11-34.1) 
39.1 6.0 2.8 1 (2.0773.03) 
7.6 1.4 1.54 (1.00-2.37) 
32.9 5.4 2.33 (1.85-2.92) 
22.1 1.9 4.32 (3-05-6.12) 
2.1 28 0.29 (0.174.46) 
188 4.2 1.62 (1.24-2.13) 
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TABLE 3. Age adjusted mortality hazard by diagnosis and severity 
Period Variable Male Female 
19851989i 
Asthma visit 
Asthma admission 
Asthma ICU 
COPD visit 
COPD admission 
COPD ICU 
1990-1995: 
Asthma visit 
Asthma admission 
COPD visit 
COPD admission 
Number of episodes 
1 
0.98 (0.80-1.20) 
2.19 (1.134.28)* 
1.50 (1,29-1.74)* 
3.06 (2.66-3.51)" 
4.76 (3.42-6.62)" 
1 
0.78 (0.55-1.09) 
1.35 (1.12~1.61j” 
1.93 (1,62-2.31)* 
1.04 (1.02-I .05>* 
i 
1.39 (1.05-1.84)* 
6.13 (2.75%13.6)* 
1.68 (1.31-2.16)” 
3.34 (2.68-4.16)" 
3.50 (1.40-8.70)" 
1 
1.22 (0.96-1.56) 
1.35 (1.09-1.67jX 
1.80 (1.46-2.20)” 
1.04 (1.02-1.06)* 
+Episode-based analysis: death after an episode between 1985 and 1989. 
IPerson-based analysis: death for those who survive 31/12/X9 up to 1995 (77.2% of the cohort), adjusted for number of visits 
during the period 1985-89, % of asthma or COPD visits, and type of referral of each visit. ‘Admission’ includes ‘admission’ 
and ‘ICU’. 
“P<O.O5 
disproportionate increase in severity of asthma with age. 
The possibility that a survival bias could explain such a 
decrease was excluded with the use of survival methods that 
split the follow-up time into narrower bands of time. The 
expected reduction of the relative risk in the oldest group 
due to the biological occurrence of death in all subjects did 
not explain the reduction of the relative risk observed in the 
middle age groups, as was shown in a study on the 
mortality effects of smoking (15). 
Causes of death among COPD patients were similar to 
those reported by other studies, although our patients were 
less likely to die of lung cancer (16,17). Our asthmatic 
patients were more likely to die of asthma than asthmatics 
selected from the general population in Denmark (18) 
while lung cancer was a more frequent cause of death in 
our men than in other studies but less frequent in women 
(18,19). These differences, mainly in lung cancer, can be 
attributed to differences in smoking patterns between 
countries (20). 
We found a decrease in the relative risk of dying 
between the analysis of the period 1985-89 and 1990-95. 
However, the two analyses are complementary but not 
identical. The relative risk of the first period refers to the 
short term risk of dying for an individual after receiving a 
certain diagnosis at a given visit, irrespective of the 
number and diagnosis of previous visits. An individual 
contributes in as many episodes as visits to emergency 
services. However, the relative risk of the second analysis, 
limited to those who survived to a given date, refers to the 
risk of dying in a longer period of time taking into account 
the personal history (number of visits and variation in the 
diagnosis within the same subject). Thus, the results of 
the second analysis suggest that an asthmatic with a 
concomitant diagnosis of COPD was at higher risk of 
dying than an asthmatic without COPD, and this 
remained true during a long period after the visit to 
emergency rooms. In addition, the second analysis showed 
that the number of admissions (whatever the diagnosis) 
slightly increased the risk of death. 
Our study illustrates that patients admitted for COPD in 
emergency services had a high mortality rate, even at young 
ages. Murray and Lopez have estimated that COPD was 
the sixth biggest cause of death in the world in 1990, with 
2.2 million deaths and will move up three places by 2020 
(21). We did not have data on specific risk factors of COPD 
at an individual level, but since smoking accounted for 90% 
of COPD, we may claim for a more stringent policy against 
cigarette production and distribution. 
In conclusion, this study with a large population of 
patients visited for an obstructive airways disease confirms 
that patients with a diagnosis of asthma have a more 
favourable prognosis than patients classified as COPD, and 
this occurred in a similar magnitude in males and females. 
As Burrows stated (22) it seems essential to distinguish 
these forms of disease in clinical and epidemiological 
studies on aetiology and natural history. 
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